Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:10/24/2007

Keryx to Host Investor Conference Call on Thursday, October 25, 2007 at

8:30am EDT

NEW YORK, Oct. 24 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer, today announced its results for the third quarter ended September 30, 2007.

At September 30, 2007, the Company had cash, cash equivalents, investment securities, interest receivable and license receivable of $82.7 million, as compared to $125.6 million at December 31, 2006. The nonrefundable license receivable of $12.0 million was received in October 2007 and related to a recent licensing agreement entered into with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd.

The net loss for the third quarter ended September 30, 2007 was $19,528,000, or $0.45 per share, compared to a net loss of $17,993,000, or $0.42 per share, for the comparable quarter in 2006, representing an increase in net loss of $1,535,000. The increase in net loss was primarily attributable to a $627,000 increase in research and development expenses related to the Company's Sulonex(TM) (sulodexide) pivotal Phase III and Phase IV clinical program, a $346,000 increase in expenses related to the Company's other clinical compounds, and a $845,000 decrease in interest and other income, offset by a $344,000 decrease in non-cash compensation expense related to stock option and restricted stock grants.

The net loss for the nine months ended September 30, 2007 was $60,801,000, or $1.40 per share, compared to a n
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 /CNW/ - A new ... on the salaries and demographic profiles of new graduates ... the Door – Building Careers for New Grads in ... Research-Based Pharmaceutical Companies (Rx&D) and features data ... Career Focus wage subsidy program from 2013 to 2015. ...
(Date:3/30/2015)... PARK, N.J. , March 30, 2015 /PRNewswire/ ... (PAMORA) under development by Shionogi & Co., Ltd., ... phase III study (COMPOSE I) for the treatment ... chronic non-cancer pain receiving opioid therapy. Study results ... daily) statistically significantly improved the frequency of spontaneous ...
(Date:3/29/2015)... , March 29, 2015 ... of important study data showing the presence ... 1,599 gynecologic cancer samples. Using Caris Molecular ... service, researchers identified expression of programmed cell ... independent of histology while its ligand (PD-L1) ...
(Date:3/27/2015)... , March 27, 2015  Neogen Corporation (NASDAQ: ... has adopted a prearranged trading plan in accordance with ... , Chairman and CEO of Neogen Corporation, is a ... Neogen Corporation common stock. Herbert does not ... was appropriate. The filing is only for a portion ...
Breaking Biology Technology:New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 2Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 3Caris Life Sciences' Multiplatform Tumor Profiling Technology Identifies Expression of PD-1 and PD-L1 in Gynecologic Malignancies 4Neogen CEO adopts 10b5-1 Trading Plan 2
... Pharmacy ... and health care providers, NASHVILLE, Tenn., ... Belmont University has,established the Belmont School of Pharmacy Department of ... Sciences,Center, which is located in downtown Nashville, provides lab and ...
... for positions, RESEARCH TRIANGLE PARK, N.C., July ... a unique fellowship,program to help postdoctoral scientists from ... The NCBC Industrial Fellowship Program will retain ... Carolina,s life-science,companies. It is designed to fill a ...
... a major supplier of,patient lifts, slings and repositioning ... additions to its "Stat" family of low friction,transfer ... Stat HandySheet(TM) and the Stat HandyTube(TM),help facilitate the ... of,patients in bed., Manufactured of extremely low ...
Cached Biology Technology:CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant 2N.C. Biotechnology Center Launches Industrial Fellowship Program 2N.C. Biotechnology Center Launches Industrial Fellowship Program 3Liko Introduces Two Additions to Its 'Stat' Family of Low Friction Sheets 2
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
(Date:3/12/2015)... , March 12, 2015 IriTech, a ... a member of the Texas Instruments Design Network, announced ... has demonstrated its IriShield USB MK2120U device during ... facility for pension distribution. The iris ... to be marketed in India ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... in Cattle Manure May Survive Composting ... actually survive the composting process. Researchers from Agriculture and ... the journal Applied and Environmental Microbiology that ... persist for long periods in the final product. ...
... lawn with acorns as they bound overhead will live to ... with their burrows, according to a University of Illinois study. ... bats live longer than earthbound animals of the same size. ... to take a closer look at the relationship between habitat ...
... With a changing climate there,s a good chance that forest ... frequent and according to one expert speaking today at ... fire in this region is difficult to predict, will always ... People should understand, however, that fire is not only inevitable ...
Cached Biology News:Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Tips from the Journals of the American Society for Microbiology 4Tree-dwelling mammals climb to the heights of longevity 2More frequent fires could aid ecosystems 2More frequent fires could aid ecosystems 3
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
V beta 5 Purified Anti-Human clone MH3-2, Isotype Mouse IgG 2a , kappa, 0.1 mg Consult technical datasheet for details....
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
...
Biology Products: